Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Neoplasm Metastasis 1Liver Neoplasms 1Fibrosis 1Colon Cancer Liver Metastasis 1Carcinoma, Pancreatic Ductal 1Breast Neoplasms 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × contrast agent BR1 × Gastrointestinal × Clear all
NCT04569799 2023-11-02

TACE

Milton S. Hershey Medical Center

Phase 4 Completed
26 enrolled 10 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT04006275 2019-09-19

Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 3 Unknown
100 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡